| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...995164H |
| P356 | DOI | 10.1371/JOURNAL.PONE.0095164 |
| P932 | PMC publication ID | 3994063 |
| P698 | PubMed publication ID | 24752177 |
| P5875 | ResearchGate publication ID | 261770795 |
| P50 | author | Thomas B. Campbell | Q89298569 |
| P2093 | author name string | Javier R Lama | |
| Sima Berendes | |||
| Amita Gupta | |||
| Barbara Detrick | |||
| Sandra W Cardoso | |||
| Fiona P Havers | |||
| ACTG A5175 PEARLS and NWCS319 Study Teams | |||
| Noluthando H Mwelase | |||
| Patcharaphan Sugandhavesa | |||
| P2860 | cites work | 1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. | Q51391175 |
| Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. | Q51678383 | ||
| Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study | Q57877133 | ||
| Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: A descriptive cross-sectional study | Q60291323 | ||
| Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population | Q64129102 | ||
| 1,25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells | Q82292920 | ||
| Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients | Q82657354 | ||
| Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase | Q24562083 | ||
| Common genetic determinants of vitamin D insufficiency: a genome-wide association study | Q24602058 | ||
| Vitamin D deficiency | Q27860616 | ||
| Vitamin D controls T cell antigen receptor signaling and activation of human T cells | Q28275206 | ||
| Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response | Q28298985 | ||
| Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality | Q33526366 | ||
| Vitamin D-binding protein and vitamin D status of black Americans and white Americans | Q33647671 | ||
| Vitamin D deficiency and sun avoidance among university students at Abu Dhabi, United Arab Emirates | Q35667408 | ||
| Vitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary study. | Q35911343 | ||
| Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis. | Q35918969 | ||
| Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States | Q36200366 | ||
| Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. | Q37312937 | ||
| Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania | Q37379462 | ||
| 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates | Q37404709 | ||
| Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial | Q38442904 | ||
| Vitamin D insufficiency and deficiency among HIV-1-infected patients in a tropical setting | Q39591171 | ||
| Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIV-infected men under care | Q39927579 | ||
| Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. | Q40280788 | ||
| Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. | Q43001305 | ||
| Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. | Q43048034 | ||
| High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients | Q43157193 | ||
| High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. | Q44585706 | ||
| Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease | Q45184117 | ||
| Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival | Q45783304 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin D | Q175621 |
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | e95164 | |
| P577 | publication date | 2014-04-21 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings | |
| P478 | volume | 9 |
| Q93151593 | Bilateral sequential femoral neck stress fractures in young adult with HIV infection on antiretroviral therapy: A case report |
| Q38835028 | Bone Loss in HIV Infection |
| Q30238946 | Bone health in HIV and hepatitis B or C infections |
| Q47213879 | CRP Genotypes Predict Increased Risk to Co-Present with Low Vitamin D and Elevated CRP in a Group of Healthy Black South African Women |
| Q40461045 | Change in serum 25-hydroxyvitamin D with antiretroviral treatment initiation and nutritional intervention in HIV-positive adults. |
| Q26853139 | HIV infection and osteoporosis |
| Q40408496 | Pilot study of the effect of cholecalciferol supplementation on hepcidin in children with chronic kidney disease: Results of the D-fense Trial |
| Q35894292 | Plasma Micronutrient Concentrations Are Altered by Antiretroviral Therapy and Lipid-Based Nutrient Supplements in Lactating HIV-Infected Malawian Women |
| Q35935280 | Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults |
| Q38997526 | Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection |
| Q40375467 | The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease. |
| Q28073157 | Vitamin D Status and Its Consequences for Health in South Africa |
| Q35962186 | Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy |
| Q38857718 | Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study |
Search more.